Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

4(66.7%)

Phase 1

1(16.7%)

Phase 2

1(16.7%)

6Total

N/A(4)

Phase 1(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT03064048Not ApplicableCompleted

Nitric Oxide Supplementation on Neurocognitive Functions in Patients With ASLD

Role: collaborator

NCT03895749Not ApplicableCompleted

Effect of a Nitric Oxide Supplementation Product on Endothelial Dysfunction and Prehypertensive Adults

Role: collaborator

NCT02593305Not ApplicableCompleted

Dietary Nitrate and Physiological Aging

Role: collaborator

NCT02679248Phase 2Terminated

A Study to Investigate the Effect of a Nitric Oxide Supplementation on Pre- and Mildly Hypertensive Adults

Role: collaborator

NCT01937754Phase 1Unknown

Study of the Effects of an Oral Nitric Oxide Supplement on Blood Pressure in Prehypertensive Adults

Role: lead

NCT01710761Not ApplicableUnknown

Effects of Neo40(TM) With Caffeine on Cycling Time Trial Performance

Role: collaborator

All 6 trials loaded